Do-not-resuscitate status and observational comparative effectiveness research in patients with septic shock

Critical Care Medicine

Volumn 42, Issue 9, 2014, Pages 2042-2047

  Bradford, Mark A ^a   Lindenauer, Peter K ^b,c   Wiener, Renda Soylemez ^a,d,e   Walkey, Allan J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYSTATE MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

comparative effectiveness research; do notresuscitate orders; outcomes research; protein C; research design; septic shock

Indexed keywords

ACTIVATED PROTEIN C;

ACIDOSIS; ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASSOCIATION; COMPARATIVE EFFECTIVENESS; DATA BASE; DO NOT RESUSCITATE; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESUSCITATION; RETROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; STUDY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CALIFORNIA; COMPARATIVE EFFECTIVENESS RESEARCH; CONTINENTAL POPULATION GROUPS; FEMALE; FIBRINOLYTIC AGENTS; HEALTH STATUS INDICATORS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROTEIN C; RESUSCITATION ORDERS; RETROSPECTIVE STUDIES; SHOCK, SEPTIC;

EID: 84906791069     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000403     Document Type: Article

References (30)

1. Lu CY: Observational studies: A review of study designs, challenges and strategies to reduce confounding. Int J Clin Pract 2009; 63:691-697
2. Concato J: Study design and "evidence" in patient-oriented research. Am J Respir Crit Care Med 2013; 187:1167-1172
3. McKee M, Britton A, Black N, et al: Methods in health services research. Interpreting the evidence: Choosing between randomised and non-randomised studies. BMJ 1999; 319:312-315
4. Lieu TA, Au D, Krishnan JA, et al; Comparative Effectiveness Research in Lung Diseases Workshop Panel: Comparative effectiveness research in lung diseases and sleep disorders: Recommendations from the National Heart, Lung, and Blood Institute workshop. Am J Respir Crit Care Med 2011; 184:848-856
5. La Puma J, Silverstein MD, Stocking CB, et al: Life-sustaining treatment. A prospective study of patients with DNR orders in a teaching hospital. Arch Intern Med 1988; 148:2193-2198
6. Beach MC, Morrison RS: The effect of do-not-resuscitate orders on physician decision-making. J Am Geriatr Soc 2002; 50:2057-2061
7. Shepardson LB, Youngner SJ, Speroff T, et al: Increased risk of death in patients with do-not-resuscitate orders. Med Care 1999; 37:727-737
8. Hemphill JC III, Newman J, Zhao S, et al: Hospital usage of early donot-resuscitate orders and outcome after intracerebral hemorrhage. Stroke 2004; 35:1130-1134
9. Connors AF Jr, Speroff T, Dawson NV, et al: The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 1996; 276:889-897
10. Carson SS, Goss CH, Patel SR, et al; American Thoracic Society Comparative Effectiveness Research Working Group: An official American Thoracic Society research statement: Comparative effectiveness research in pulmonary, critical care, and sleep medicine. Am J Respir Crit Care Med 2013; 188:1253-1261
11. Kalil AC, LaRosa SP: Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: A meta-analysis and metaregression. Lancet Infect Dis 2012; 12:678-686
12. Bernard GR, Vincent JL, Laterre PF, et al; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
13. Abraham E, Laterre PF, Garg R, et al; Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group: Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005; 353:1332-1341
14. Ranieri VM, Thompson BT, Barie PS, et al; PROWESS-SHOCK Study Group: Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012; 366:2055-2064
15. Agency for Healthcare Research and Quality: HCUP-US SID overview. Available at: http://www.hcup-us.ahrq.gov/sidoverview.jsp. Accessed August 21, 2013
16. Healthcare Cost and Utilization Project: Introduction to the HCUP state inpatient databases (SID). Available at: http://www.hcupus. ahrq.gov/db/state/ siddist/Introduction-to-SID.pdf. Accessed August 21, 2013
17. California Office of Statewide Health Planning and Development: Patient discharge data file documentation, public version January-December 2007. Available at: http://www.oshpd.ca.gov/HID/Products/PatDischargeData/ PublicDataSet/Doc/PD07docwapp.pdf. Accessed October 22, 2013
18. Goldman LE, Chu PW, Osmond D, et al: Accuracy of do not resuscitate (DNR) in administrative data. Med Care Res Rev 2013; 70:98-112
19. Glance LG, Dick AW, Osler TM, et al: Accuracy of hospital report cards based on administrative data. Health Serv Res 2006; 41:1413-1437
20. Glance LG, Dick AW, Osler TM, et al: Does date stamping ICD-9-CM codes increase the value of clinical information in administrative data? Health Serv Res 2006; 41:231-251
21. Coffey R, Milenkov M, Andrews RM: The case for the present-onadmission (POA) indicator. HCUP methods series report 2006-1. Available at: http://www.hcup-us.ahrq.gov/reports/methods/2006-1. pdf. Accessed July 7, 2011
22. Poulose JT, Cartin-Ceba R, Shoja A, et al: Comparison of international classification of disease-ninth revision (ICD-9) coding with retrospective case review for the diagnosis of septic shock [abstract]. Am J Respir Crit Care Med 2009; 179:A4691
23. Whittaker SA, Mikkelsen ME, Gaieski DF, et al: Severe sepsis cohorts derived from claims-based strategies appear to be biased toward a more severely ill patient population. Crit Care Med 2013; 41:945-953
24. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
25. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44:837-845
26. Lindenauer PK, Rothberg MB, Nathanson BH, et al: Activated protein C and hospital mortality in septic shock: A propensity-matched analysis. Crit Care Med 2010; 38:1101-1107
27. Martin G, Brunkhorst FM, Janes JM, et al: The international PROGRESS registry of patients with severe sepsis: Drotrecogin alfa (activated) use and patient outcomes. Crit Care 2009; 13:R103
28. Teres D: Trends from the United States with end of life decisions in the intensive care unit. Intensive Care Med 1993; 19:316-322
29. Kroch EA, Johnson M, Martin J, et al: Making hospital mortality measurement more meaningful: Incorporating advance directives and palliative care designations. Am J Med Qual 2010; 25:24-33
30. Tabak YP, Johannes RS, Silber JH, et al: Should do-not-resuscitate status be included as a mortality risk adjuster? The impact of DNR variations on performance reporting. Med Care 2005; 43: 658-666